Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Jan 28, 2021

SELL
$78.74 - $139.5 $433,070 - $767,250
-5,500 Reduced 56.12%
4,300 $116,000
Q3 2020

Nov 03, 2020

SELL
$79.44 - $178.51 $174,768 - $392,722
-2,200 Reduced 18.33%
9,800 $514,000
Q2 2020

Jul 29, 2020

BUY
$13.86 - $83.61 $166,320 - $1 Million
12,000 New
12,000 $559,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $704M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.